Current treatment strategies for papillary thyroid microcarcinoma
Surgical treatment of papillary thyroid microcarcinoma (PTMC) is evolving more and more into a controversial issue. As in Japan more than 50% of PTMCs are only observed, an increasing number of physicians in the western world are calling for active surveillance instead of lobectomy or total thyroidectomy. Unifocal carcinomas of older patients without extrathyroidal growth or lymph node involvement seem to be candidates for active surveillance. First estimations for a lifelong observation show that patients <30 years old will have a probability of tumor progression of more than 60%. A decision for surgery versus active surveillance has to weigh up all the arguments for and against, which have to be discussed and planned in detail together with the patient.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:91 |
|---|---|
| Enthalten in: |
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen - 91(2020), 12 vom: 10. Dez., Seite 994-998 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Aktuelle Therapiestrategien beim papillären Mikrokarzinom der Schilddrüse |
|---|
| Beteiligte Personen: |
Weber, Theresia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Active surveillance |
|---|
| Anmerkungen: |
Date Completed 04.12.2020 Date Revised 14.12.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00104-020-01263-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM313511675 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM313511675 | ||
| 003 | DE-627 | ||
| 005 | 20231225150731.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00104-020-01263-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1045.xml |
| 035 | |a (DE-627)NLM313511675 | ||
| 035 | |a (NLM)32776249 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Weber, Theresia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Current treatment strategies for papillary thyroid microcarcinoma |
| 246 | 3 | 3 | |a Aktuelle Therapiestrategien beim papillären Mikrokarzinom der Schilddrüse |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.12.2020 | ||
| 500 | |a Date Revised 14.12.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Surgical treatment of papillary thyroid microcarcinoma (PTMC) is evolving more and more into a controversial issue. As in Japan more than 50% of PTMCs are only observed, an increasing number of physicians in the western world are calling for active surveillance instead of lobectomy or total thyroidectomy. Unifocal carcinomas of older patients without extrathyroidal growth or lymph node involvement seem to be candidates for active surveillance. First estimations for a lifelong observation show that patients <30 years old will have a probability of tumor progression of more than 60%. A decision for surgery versus active surveillance has to weigh up all the arguments for and against, which have to be discussed and planned in detail together with the patient | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Active surveillance | |
| 650 | 4 | |a Lobectomy | |
| 650 | 4 | |a Papillary thyroid carcinoma | |
| 650 | 4 | |a Risk factors | |
| 650 | 4 | |a Thyroidectomy | |
| 773 | 0 | 8 | |i Enthalten in |t Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen |d 1946 |g 91(2020), 12 vom: 10. Dez., Seite 994-998 |w (DE-627)NLM000002771 |x 1433-0385 |7 nnns |
| 773 | 1 | 8 | |g volume:91 |g year:2020 |g number:12 |g day:10 |g month:12 |g pages:994-998 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00104-020-01263-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 91 |j 2020 |e 12 |b 10 |c 12 |h 994-998 | ||